Earlier Announced, Aligos Therapeutics Has Been Awarded A $1.3M NIH Contract To Conduct Clinical Development Of A Compound For The Treatment Of Covid-19
Earlier Announced, Aligos Therapeutics Has Been Awarded A $1.3M NIH Contract To Conduct Clinical Development Of A Compound For The Treatment Of Covid-19
早些时候宣布，Aligos Therapeutics已获得一份价值130万美元的美国国立卫生研究院合同，用于对治疗Covid-19的化合物进行临床开发
Earlier Announced, Aligos Therapeutics Has Been Awarded A $1.3M NIH Contract To Conduct Clinical Development Of A Compound For The Treatment Of Covid-19
早些时候宣布，Aligos Therapeutics已获得一份价值130万美元的美国国立卫生研究院合同，用于对治疗Covid-19的化合物进行临床开发
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。